It has nothing to do with them working together it was the face that Einhorn was pumping his MRVL and STX when the chart showed pured manipulation in July or June of 2012, it was all over the charts, that was when Einhorn was out touting STX and MRVL.
I would actually agree with Marvell or STX it back my theory of Greenlight Capital, I through at pipster about a year and half ago.
Why did you not read the trial and neither did AF, I bet.
I am long and until I see it, I do not believe it. Shortly are usually goals of six months or less. Why can he not say in 3 days?
Pipster I will be the fist to congratulate you if your right and first one to tell you I told you so If they do file. There has been something not right about this company since the first night I challenged and said there is some consipracy theory going on with OCZ and somebody else. It might have been with themselves and it might be with another company or hedgefund like I suggested at the time and this was almost a year and two months ago.
I have not listened to the call yet but anything LP says you have to multiply everything by 90 percent. If he says there is 30,000 bopd sales are probably 27,000. He is been accurate in settin production trends and drilling skills but the numbers I have learned that 90 percent of production is really closer to the sales and average quarterly increases were around 14 to 18 percent but much greater this quarter. I am still waiting to see the decline rate in the wells that is something I would be cautious but it does seem that we are no longer a 5 billion dollar takeout but much more.
I am not arguing with you but hey they have not done anything for shareholders, isn't that why we are here. Until they place the cards on the table and do it so honestly and have had plenty of time they have not done anything for shareholders.
There is a difference between proteins and immunotherapy even though some get the definitions confused. Most of Celldex products are a protein or antibody type product. Really only rindo is the true immunotherapy. Immunotherapy can be classifed as an agent the helps propel the body to gain strength against a disease. Sometimes people classify vaccines as immunotherapy. But Celldex is really a protein or antibody company first and just so happens they have mixtures of other mechanisms of actions. Its is a very unique product portfolio. I do believe though there products are being used as a disease marker such as the breast cancer agent.
Delisting makes no sense from a business perspective you automatically lose goodwill value and any leverage in negotiations and put this with any kind of loss in continual revenue and you go bankrupt. De-listing would be plum stupid. I think OCZ is afraid to tell the truth personally, I want to see real men stand up and face what they need to and not take money from those that actually believe in the products.
Tell everyone for your information. YERVOY WAS a Product from the CELLDEX parent comany Medarex before they branched off. Medarex share holders were so screwed in that deal, and I am talking billions of dollars alone. This is why I hope CLDX survives and thrives.
It would have to be awful compelling news. I dare say they settle it in before the presentation date. I cannot remember a biotech stock moving on such news before the meeting especially cancer agents. I have seen lifestyle drugs, I think people are really just beginning to understand that CLDX products are going to have muliple indications and opportunties in the market place. Something many of the loyals have understood about the pipeline and true potential. I will be happy either way as long as we stay above 30.
OCZ Technology Group, a worldwide leader in innovative, ultra-highperformance and high Samsung Galaxy S4 Hüllen reliability memory, today disclosed the collaborativeeffort between themselves and ASUS Samsung Galaxy S3 i9300 hoesjes to bring the enthusiast community theindustry’s first motherboard and memory solution rated for 1000MHz.
OCZ hullen samsung Technology Group, a worldwide leader in innovative, ultra-high performance and high reliability memory, today expanded their memory lineup for AMD enthusiasts and power users with new DDR3 Hüllen Samsung Galaxy S2 kits qualified and optimized specifically for Hüllen Samsung Galaxy Note 2 the AM3 platform. The new low-voltage kits were designed exclusively for AMD’s transition to DDR3 and are tailored to make full use of the latest computing environments as well as establish a future-proof system with restricted voltage requirements.
OCZ Technology Group, a worldwide leader in innovative, ultra-highperformance and high reliability memory, today announced the next addition toOCZ’s line of NVIDIA® certified Platinum DDR2 memory modules. The new PC2-8500series is SLI™ certified ensuring ultimate breakthrough compatibility foradvanced SLI platform performance.